Bright Science. Brighter Living™ with biomedical materials
DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees delivering innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.
DSM is committed to helping our customers develop effective, customized solutions to medical issues facing the world today and tomorrow. Our biomedical materials are contributing to diagnostic procedures and medical therapies that help people lead longer, healthier and more active lives.
Making an impact in medicine
Driving our biomedical materials business is a thorough understanding of how advanced materials can be used in the human body to strengthen or replace body parts and accurately deliver medicines. Our materials and customized solutions are used by a variety of medical device manufacturers in numerous therapeutic markets including cardiovascular, vascular, orthopedic, ophthalmic, urinary, neurologic, pain management, diabetes, diagnostic and women’s health.
Furthermore, we provide our next-generation customized polymers to leading biopharmaceutical companies for them to use as they design their drug delivery systems. Leveraging our expertise in life sciences and materials sciences, we’re also delving into the exciting world of regenerative medicine – work that could pave the way for major developments in the treatment of orthopedic injury and disease. Areas of particular interest include creation of scaffolds and matrices, with or without cells or biologics that may enhance regeneration of bone, cartilage and other connective tissues.
At DSM, we’re doing our part to protect the planet and safeguard the people who inhabit it. Global responsibility and sustainability are at the heart of our efforts – no matter what market or end user we serve.
We’re developing solutions to reduce the eco-footprint of our company and that of our customers. For example, one of our manufacturing facilities now uses significantly less energy, with far lower emissions of greenhouse gases. We’re focused on more efficient use of raw materials and processing, helping our customers develop products that use less energy and reduce emissions in their operations. And we’re dedicated to using materials that are easier to dispose of, with less waste, including developing eco-friendly packaging.
In addition to advancing the biomedical materials markets in North America and Western Europe, DSM is increasingly focusing on high-growth economies such as Asia, Central and Eastern Europe and Latin America. We bring a global perspective to the challenges in our markets; as well as to our existing and potential customers and the many patients benefiting from our biomaterials science.